Sign Up to like & get
recommendations!
1
Published in 2019 at "International Journal of Clinical Practice"
DOI: 10.1111/ijcp.13397
Abstract: Cariprazine is an oral antipsychotic approved in the US for the treatment of schizophrenia, acute bipolar mania, and most recently, bipolar depression. The aim of this systematic review is to describe the efficacy, tolerability and…
read more here.
Keywords:
depression number;
bipolar depression;
cariprazine bipolar;
number ... See more keywords